InvestorsHub Logo
Followers 74
Posts 15839
Boards Moderated 0
Alias Born 04/26/2010

Re: marzan post# 119098

Friday, 12/15/2017 2:21:11 PM

Friday, December 15, 2017 2:21:11 PM

Post# of 423564

it doesn't matter if it is an approved drug like Epanova or unapproved drug, the DS are violating the patent rights and infringing the percentage composition of the components or molecular compositions or the range of them



Yes, it does matter - all of AMRN's patents are for treating medical conditions, the "percentage composition of the components or molecular compositions" are just parts of the patents - you have to violate the entire patent to get sued AFAIK - the method of use. That's why patents are so broadly written, to cover any possible use of the invention - I've written about that before here how I was robbed of a patent that could have allowed me to retire a rich man because I naively tried to patent an invention for the product I used the technology to build, not any or all potential uses for the technology that made it work. After my agency determined nobody wanted to produce the product because it had such a limited market, the manufacturers they contacted were free to use the technology, and boy did they - sold millions of units using the technology for other uses - a very costly learning experience for me.

The Thought Police: To censor and protect. Craig Bruce

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News